Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study

In this retrospective, IRB-exempt study, we analyzed data from 68 patients diagnosed with glioblastoma (GBM) in two institutions and investigated the relationship between tumor shape, quantified using algorithmic analysis of magnetic resonance images, and survival. Each patient’s Fluid Attenuated Inversion Recovery (FLAIR) abnormality and enhancing tumor were manually delineated, and tumor shape was analyzed by automatic computer algorithms. Five features were automatically extracted from the images to quantify the extent of irregularity in tumor shape in two and three dimensions. Univariate Cox proportional hazard regression analysis was performed to determine how prognostic each feature was of survival. Kaplan Meier analysis was performed to illustrate the prognostic value of each feature. To determine whether the proposed quantitative shape features have additional prognostic value compared with standard clinical features, we controlled for tumor volume, patient age, and Karnofsky Performance Score (KPS). The FLAIR-based bounding ellipsoid volume ratio (BEVR), a 3D complexity measure, was strongly prognostic of survival, with a hazard ratio of 0.36 (95% CI 0.20–0.65), and remained significant in regression analysis after controlling for other clinical factors (P = 0.0061). Three enhancing-tumor based shape features were prognostic of survival independently of clinical factors: BEVR (P = 0.0008), margin fluctuation (P = 0.0013), and angular standard deviation (P = 0.0078). Algorithmically assessed tumor shape is statistically significantly prognostic of survival for patients with GBM independently of patient age, KPS, and tumor volume. This shows promise for extending the utility of MR imaging in treatment of GBM patients.

[1]  Tracy T Batchelor,et al.  Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in Glioblastoma , 2005, Clinical Cancer Research.

[2]  Maciej A. Mazurowski,et al.  Computer-extracted MR imaging features are associated with survival in glioblastoma patients , 2014, Journal of Neuro-Oncology.

[3]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[4]  William D. Dunn,et al.  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. , 2013, Radiology.

[5]  L. Khachiyan.  Polynomial algorithms in linear programming , 1980 .

[6]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[7]  M. Sailer,et al.  Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study , 2010, Journal of Neuro-Oncology.

[8]  Leslie M. Collins,et al.  Predicting outcomes in glioblastoma patients using computerized analysis of tumor shape: preliminary data , 2016, SPIE Medical Imaging.

[9]  Luke Macyszyn,et al.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. , 2016, Neuro-oncology.

[10]  Lei Xing,et al.  Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images. , 2016, Radiology.

[11]  Leslie M. Collins,et al.  Radiogenomics of glioblastoma: a pilot multi-institutional study to investigate a relationship between tumor shape features and tumor molecular subtype , 2016, SPIE Medical Imaging.

[12]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[13]  David Gutman,et al.  Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. , 2013, Radiology.

[14]  N. Moshtagh.  MINIMUM VOLUME ENCLOSING ELLIPSOIDS , 2005 .

[15]  Nikos Dimitropoulos,et al.  Multi-scaled morphological features for the characterization of mammographic masses using statistical classification schemes , 2007, Artif. Intell. Medicine.

[16]  D. Silbergeld,et al.  Isolation and characterization of human malignant glioma cells from histologically normal brain. , 1997, Journal of neurosurgery.

[17]  S. Boujraf,et al.  Pott's disease in children , 2011, Surgical neurology international.

[18]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[19]  James I. Ausman.  Announcement of new journal and call for submission of papers: Surgical Neurology International , 2010, Surgical neurology international.

[20]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[21]  T. Cloughesy,et al.  Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma , 2012, American Journal of Neuroradiology.

[22]  George Fountzilas,et al.  Volumetric and MGMT parameters in glioblastoma patients: Survival analysis , 2012, BMC Cancer.

[23]  Raymond Sawaya,et al.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.

[24]  Tej D. Azad,et al.  Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities , 2015, Science Translational Medicine.

[25]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[26]  B. Tucer,et al.  Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas. , 2011, Turkish neurosurgery.

[27]  Jordan M. Malof,et al.  Imaging descriptors improve the predictive power of survival models for glioblastoma patients. , 2013, Neuro-oncology.

[28]  S. Horvath,et al.  Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2 , 2007, Clinical Cancer Research.

[29]  Olivier Gevaert,et al.  Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. , 2015, Journal of neuroradiology. Journal de neuroradiologie.

[30]  Eduard Schreibmann,et al.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials. , 2014, Translational oncology.

[31]  R. Gillies,et al.  Quantitative imaging in cancer evolution and ecology. , 2013, Radiology.

[32]  M. Giger,et al.  Computerized characterization of mammographic masses: analysis of spiculation. , 1994, Cancer letters.

[33]  G. Ojemann,et al.  Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival , 2010, Surgical neurology international.

[34]  S. Plevritis,et al.  Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. , 2014, Radiology.

[35]  Keith Paulsen,et al.  Genetics of glioblastoma: a window into its imaging and histopathologic variability. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[36]  B. Shadbolt,et al.  Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): Findings of a multicenter Australian study , 2011, Surgical neurology international.

[37]  K. Sartor,et al.  Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and Prognosis , 1995 .

[38]  A. Verma.  MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .

[39]  Max Wintermark,et al.  Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. , 2015, Neuro-oncology.

[40]  J. Uhm.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[41]  Paul S Mischel,et al.  MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.

[42]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[43]  N. Obuchowski,et al.  Quantitative classification of breast tumors in digitized mammograms. , 1996, Medical physics.